We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

The EPIC-XS Consortium Kicks Off

Article   Jun 14, 2019 | By Juan Antonio Vizcaino (EMBL-EBI, UK) and Julia Chamot-Rooke (Institut Pasteur, France)

 
The EPIC-XS Consortium Kicks Off

EPIC-XS consortium members who attended the kick-off meeting in Amsterdam, from left to right: Javier Munoz, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain; Marteen Altelaar, Utrecht University, The Netherlands; Tiziana Bonaldi, Inistituto Europeo di Oncologia, Milan, Italy, and Kris Gevaert, Vlaams Instituut voor Biotechnologie, Ghent.

 
 
Advertisement
 

RELATED ARTICLES

Keep Up-to-Date With COVID-19 Vaccine Development

Article

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

A New Way To Characterize Glycans From SARS-CoV-2's Spike Protein

Article

Dr Rod Chalk, head of mass spectrometry at The Centre for Medicines Discovery (previously the Structural Genomics Consortium) has developed a novel mass spectrometry-based method for characterizing glycans from the Spike protein. In this interview, Chalk discusses the method and how it can be adopted in SARS-CoV-2 research and beyond.

READ MORE

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Diagnostics Drug Discovery Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE